Medical Economics March 28, 2025
Robert Gabbay, MD, PhD, FACP, Austin Littrell

Key Takeaways

  • Diabetes affects millions globally, with many unaware of their condition, leading to severe complications and high healthcare costs.
  • GLP-1-based therapies show promise in managing obesity and diabetes, but accessibility and cost remain challenges.
  • Technological advancements, like continuous glucose monitors, enhance diabetes management and patient engagement.
  • Research into islet cell transplantation and genetic modification offers hope for a diabetes cure, addressing immune system challenges.

GLP drugs, new technology and breakthroughs in research are transforming diabetes care — and fueling hope for a cure.

Diabetes has been a massive problem not just in the U.S. but also around the world. Much of the focus on treating the disease to date has focused on glucose control, but new options...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Digital Health, Pharma / Biotech, Technology, Telehealth
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions

Share This Article